[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339116-105":3,"doc-detail-339116-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","single-component-dual-functional-autoboost-strategy-by-dual-photodynamic-and-cyclooxygenase-2-inhibition-for-lung-cancer-and-spinal-metastasis","Single-Component Dual-Functional Autoboost Strategy by Dual Photodynamic and Cyclooxygenase-2 Inhibition for Lung Cancer and Spinal Metastasis","","Coloading adjuvant drugs or biomacromolecules with photosensitizers into nanoparticles is a common strategy for photodynamic therapy (PDT), yet it is difficult to co-load oppositely charged components and synchronously regulate release. The study presents a single-component dual-functional prodrug activated by tumor microenvironment (TME)-generated HOCl. DHU-CBA2, made by grafting indomethacin onto methylene blue, triggers HOCl-responsive dual-drug release in vitro and in vivo. PDT induces immunogenic death while stimulating COX-2; indomethacin simultaneously blocks immune escape mediated by downstream prostaglandins E2 and IDO1, enhancing CD8+ T-cell infiltration and antitumor immunity against lung cancer and spinal metastasis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/single-component-dual-functional-autoboost-strategy-by-dual-photodynamic-and-cyclooxygenase-2-inhibition-for-lung-cancer-and-spinal-metastasis/339116/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/single-component-dual-functional-autoboost-strategy-by-dual-photodynamic-and-cyclooxygenase-2-inhibition-for-lung-cancer-and-spinal-metastasis/339116.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the single-component dual-functional prodrug strategy address?","Question",{"text":63,"@type":64},"It targets the difficulty of co-loading oppositely charged photosensitizers and adjuvants into one nanomaterial and the challenge of coordinating drug release while regulating tumor treatment activity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is DHU-CBA2 activated and what does it release?",{"text":68,"@type":64},"DHU-CBA2 is specifically activated by TME-generated HOCl, which enables simultaneous release of two drugs in both in vitro and in vivo settings.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the treatment achieve antitumor immune effects?",{"text":72,"@type":64},"PDT drives immunogenic cell death but also increases COX-2, and the resulting immune escape pathways are rescued by indomethacin release, which promotes CD8+ T-cell infiltration and a robust antitumor immune response.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339116,1790362832,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d",8,"RESEARCH ARTICLE  \n[www.advancedscience.com](www.advancedscience.com)  \nSingle-Component Dual-Functional Autoboost Strategy by Dual Photodynamic and Cyclooxygenase-2 Inhibition for Lung Cancer and Spinal Metastasis  \nBen Wang, Zhen-Ni Lu, Meng-Xiong Song, Xiao-Wen He, Zhi-Chao Hu, Hai-Feng Liang, Hong-Wei Lu, Qing Chen, Bing Liang, Tao Yi,* Peng Wei,* Li-Bo Jiang,* and Jian Dong*  \nColoading adjuvant drugs or biomacromolecules with photosensitizers into nanoparticles to enhance the eﬃciency of photodynamic therapy (PDT) is a common strategy. However, it is diﬃcult to load positively charged photosensitizers and negatively charged adjuvants into the same nanomaterial and further regulate drug release simultaneously. Herein, a single-component dual-functional prodrug strategy is reported for tumor treatment speciﬁcally activated by tumor microenvironment (TME)-generated HOCl. A representative prodrug (DHU-CBA2) is constructed using indomethacin grafted with methylene blue (MB). DHU-CBA2 exhibited high sensitivity toward HOCl and achieved simultaneous release of dual drugs in vitro and in vivo. DHU-CBA2 shows eﬀective antitumor activity against lung cancer and spinal metastases via PDT and cyclooxygenase-2 (COX-2) inhibition. Mechanistically, PDT induces immunogenic cell death but stimulates the gene encoding COX-2. Downstream prostaglandins E2 and Indoleamine 2,3 dioxygenase 1 (IDO1) mediate immune escape in the TME, which is rescued by the simultaneous release of indomethacin. DHU-CBA2 promotes inﬁltration and function of CD8+ T cells, thus inducing a robust antitumor immune response. This work provides an autoboost strategy for a single-component dual-functional prodrug activated by TME-speciﬁc HOCl, thereby achieving favorable tumor treatment via the synergistic therapy of PDT and a COX-2 inhibitor.  \n1. Introduction  \nLung cancer (LC), the leading cause of global cancer-related deaths, severely threatens personal health and causes an enormous economic burden. [1] Conventional therapies, including surgery, chemotherapy, and radiotherapy, have inevitable systemic side eﬀects, such as sequelae of anesthesia, hemorrhage, and systemic multi-organ toxicity.[2] Fortunately, photodynamic therapy (PDT) holds promise for reducing the side eﬀects during cancer treatment. [2,3] This emerging cancer treatment converts oxygen (O2 ) into singlet oxygen (1 O2 ) to kill cancer cells and has unique advantages, including noninvasiveness, excellent controllability, and minimal toxicity.[4] However, previous studies have reported that the antitumor capacity of PDT alone is too limited to completely or highly eﬃciently ablate tumors. Various approaches have been used to combine PDT with other treatments, such as chemotherapy. However, these treatments aim to improve the eﬀectiveness of chemotherapeutic drugs rather  \nthan fundamentally address the drawbacks of PDT. In addition to directly killing tumor tissues, some studies have reported that PDT exhibits a powerful function in immune activation, known  \nB. Wang, Z.-C. Hu, H.-F. Liang, H.-W. Lu, Q. Chen, B. Liang, L.-B. Jiang, J. Dong  \nDepartment of Orthopaedic Surgery  \nZhongshan Hospital Fudan University Shanghai 200032, China  \nE-mail: [jiang.libo@zs-hospital.sh.cn](jiang.libo@zs-hospital.sh.cn); [dong.jian@zs-hospitcal.sh.cn](dong.jian@zs-hospitcal.sh.cn)  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202303981](https://doi.org/10.1002/advs.202303981)[ ](https://doi.org/10.1002/advs.202303981)© 2024 The Authors. Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/advs.202303981  \nZ.-N. Lu, T. Yi, P. Wei  \nState Key Laboratory for Modiﬁcation of Chemical Fibers and Polymer Materials  \nCollege of Chemistry and Che","cbCait2jArH02Prk","https://ap.wps.com/l/cbCait2jArH02Prk","pdf",14797937,11,"English","# Introduction\n## Background and limitations of conventional lung cancer therapies\n## Rationale for photodynamic therapy (PDT)\n## PDT immunogenicity and immune microenvironment drawbacks\n## Role of COX-2 and downstream mediators in immune escape","[{\"question\":\"What problem does the single-component dual-functional prodrug strategy address?\",\"answer\":\"It targets the difficulty of co-loading oppositely charged photosensitizers and adjuvants into one nanomaterial and the challenge of coordinating drug release while regulating tumor treatment activity.\"},{\"question\":\"How is DHU-CBA2 activated and what does it release?\",\"answer\":\"DHU-CBA2 is specifically activated by TME-generated HOCl, which enables simultaneous release of two drugs in both in vitro and in vivo settings.\"},{\"question\":\"How does the treatment achieve antitumor immune effects?\",\"answer\":\"PDT drives immunogenic cell death but also increases COX-2, and the resulting immune escape pathways are rescued by indomethacin release, which promotes CD8+ T-cell infiltration and a robust antitumor immune response.\"}]","Single-Component Dual-Functional Autoboost Strategy by Dual Photodynamic and Cyclooxygenase-2 Inhibition for Lung Cancer and Spinal Metastasis | PDF",1790027987,28,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf62e929f8a94ebb60cdf0599e74d0f7.webp",983,1291,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f26b0cb22e2b0d810337450e8c5aa9a.webp",982,1290,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/898bfb543331da93f66b7d76036ab8c7.webp",981,1289,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3c40653227b7703a52d8a783fa58f3c.webp",980,1287,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,160],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":157,"doc_module":4,"doc_module_name":25,"category_name":158,"show_sort_weight":157,"slug":159},10,"Lifestyle","lifestyle",{"id":161,"doc_module":4,"doc_module_name":25,"category_name":162,"show_sort_weight":131,"slug":163},19,"General","general"]